Views & Analysis Women in Science: AstraZeneca We speak to three of AstraZeneca’s senior leaders about their careers, the future of their therapy areas and how the industry can encourage and support more women to purs
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.